Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo
Epidemiologic studies implicate vitamin D status as a factor that influences growth of EGFR mutant lung cancers. However, laboratory based evidence of the biological effect of vitamin D in this disease is lacking. To fill this knowledge gap, we determined vitamin D receptor (VDR) expression in human...
Main Authors: | Verone-Boyle, Alissa R., Shoemaker, Suzanne, Attwood, Kristopher, Morrison, Carl D., Makowski, Andrew J., Battaglia, Sebastiano, Hershberger, Pamela A. |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808047/ |
Similar Items
-
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment
by: Upadhyay, Santosh Kumar, et al.
Published: (2013) -
Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation
by: Mazahery, Hajar, et al.
Published: (2015) -
Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling
by: Chun, Rene F., et al.
Published: (2012) -
Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling.
by: Rene F Chun, et al. -
Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation
by: Dusso, Adriana S
Published: (2011)